| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebd4e043b187a0b8ce2847c163b8595b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate |
2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c0427e026f238ff10a008b1fc38bf32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db6e84e1a8f260679ce91d339d1d2d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a6b721c0fadb9f9e1e02b640c95e6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a23adbb659c14c493fc0be8599af9e32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e353ed57487c547b5529094deff430b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d555647dc67bdc21b2e1586ebd2aa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c36ae4f64e54bd5c9d0cf4cccd55755d |
| publicationDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110898210-A |
| titleOfInvention |
Application of a recombinant secreted DDRGK1 |
| abstract |
The present invention relates to the application of a recombinant secretory DDRGK1. After experimental demonstration, it is found that the recombinant secretory DDRGK1 can be used in the preparation of drugs for treating intervertebral disc degeneration, osteoarthritis and cartilage-related diseases, or for preparing drugs for treating fractures or bone defects. The drug has opened up new ideas for the treatment of bone and joint diseases and obtained relatively solid scientific evidence, expanding the further clinical application of recombinant secreted DDRGK1. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021098240-A1 |
| priorityDate |
2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |